Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF LEGAL OFFICER, SECRETARY | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,616 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 5,350 · Balance 115,611 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 124,763 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 426 · Balance 125,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,573 · Balance 117,616 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,700 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 5,350 · Balance 10,700 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,553 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 426 · Balance 2,553 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2023 Filed Sep 6, 2023 20:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000044 · wk-form4_1694031459.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,512 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 02, 2023 Filed Jun 5, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 939 | $24.38 | $22,893.76 |
DisclosureSEC source: 0001415889-23-009205 · form4-06052023_080617.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,631 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-009205 · form4-06052023_080617.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,167 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-009205 · form4-06052023_080617.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 53,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004413 · form4-03072023_090308.xml · derivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,013 Underlying: Common Stock · 53,013 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:14 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,096 | $25.91 | $132,042.46 |
DisclosureSEC source: 0001415889-23-004413 · form4-03072023_090308.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,689 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 727 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 16 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 730 Underlying: Common Stock · 727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2023, the reporting person earned 1,457 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F13 · derivative.expiration_date: On March 2, 2023, the reporting person earned 1,457 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 1,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 15 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457 Underlying: Common Stock · 1,457 shares Expires not disclosed F10 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022. F12 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. F12 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 14 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446 Underlying: Common Stock · 1,445 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 13 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,912 Underlying: Common Stock · 1,912 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 831 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 12 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 831 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,661 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F7 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,661 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F6 · derivative.expiration_date: On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,941 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 8 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 831 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,570 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,877 | $25.36 | $98,328.47 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,629 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 7,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,048 Underlying: Common Stock · 7,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 7,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004103 · form4-03032023_090316.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:16 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 78,768 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006092 · form4-06032022_010612.xml · derivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,768 Underlying: Common Stock · 78,768 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,879 | $66.74 | $258,872.82 |
DisclosureSEC source: 0001179110-22-002054 · edgar.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,983 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 4,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002054 · edgar.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,491 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 26, 2020, the reporting person earned 13,471 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. F5 · derivative.expiration_date: On February 26, 2020, the reporting person earned 13,471 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 3,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002054 · edgar.xml · derivative · entry 4 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,454 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 10,363 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,491 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002054 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,454 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002054 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,513 | $70.24 | $246,749.61 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,917 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 13 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,891 Underlying: Common Stock · 1,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F13 · derivative.expiration_date: On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 4,337 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 12 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,337 Underlying: Common Stock · 4,337 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's 2021 financial results F12 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. F12 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,824 Underlying: Common Stock · 1,912 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F10 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 830 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831 Underlying: Common Stock · 830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,661 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,661 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 1,661 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,661 Underlying: Common Stock · 1,661 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F7 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021. F8 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. F8 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,300 Underlying: Common Stock · 3,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F5 · derivative.expiration_date: On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,941 Underlying: Common Stock · 1,942 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 3,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:35 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,942 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002585 · form4-03042022_030344.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:40 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 22,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001918 · edgar.xml · derivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,571 Underlying: Common Stock · 22,571 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $136.00 | $272,000.00 |
DisclosureSEC source: 0001179110-21-010168 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 25, 2020. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $137.09 | $274,180.00 |
DisclosureSEC source: 0001179110-21-009488 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 25, 2020. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,000 | $133.11 | $266,220.00 |
DisclosureSEC source: 0001179110-21-008824 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 25, 2020. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,163 | $143.49 | $310,368.87 |
DisclosureSEC source: 0001179110-21-008497 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 25, 2020. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 558 | $157.05 | $87,633.90 |
DisclosureSEC source: 0001179110-21-006776 · edgar.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,163 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-006776 · edgar.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,136 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 14, 2017, the reporting person was was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on June 14, 2018. F2 · derivative.expiration_date: On June 14, 2017, the reporting person was was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on June 14, 2018. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,136 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-006776 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 22:52 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,165 | $183.18 | $762,961.36 |
DisclosureSEC source: 0001179110-21-003158 · edgar.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,585 F1 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.